A patent dispute over the heartburn drug Protonix escalated Monday when Wyeth said it will sue to recover lost profits from sales of Teva Pharmaceutical Industries Ltd.'s generic version.
TEL AVIV (MarketWatch) -- Teva Pharmaceutical Industries Ltd. lifted its 2007 earnings estimate Monday as the generic drugmaker launched a version of the Protonix acid-reflux treatment.